Comparison of Short-Term Outcomes of Induction Therapy with Alemtuzumab versus Rabbit Antithymocyte Globulin in Lung Transplantation

被引：0
|
作者：
Liu, V. [1 ]
Soto-Arenall, M. W. [1 ]
Patel, A. [1 ]
机构：
[1] Mayo Clin, Pharm, Jacksonville, FL 32224 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2020年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
C-300
引用
收藏
页码：1141 / 1142
页数：2
相关论文
共 50 条
  • [31] The impact of antithymocyte globulin on short-term toxicity after allogeneic stem cell transplantation
    R Pihusch
    E Holler
    D Mühlbayer
    P Göhring
    O Stötzer
    M Pihusch
    E Hiller
    H-J Kolb
    Bone Marrow Transplantation, 2002, 30 : 347 - 354
  • [32] The impact of antithymocyte globulin on short-term toxicity after allogeneic stem cell transplantation
    Pihusch, R
    Holler, E
    Mühlbayer, D
    Göhring, P
    Stötzer, O
    Pihusch, M
    Hiller, E
    Kolb, HJ
    BONE MARROW TRANSPLANTATION, 2002, 30 (06) : 347 - 354
  • [33] Long-Term Outcomes after Alemtuzumab Induction in Lung Transplantation
    Shyu, S.
    Dew, M. A.
    Dabbs, A. De Vito
    Crespo, M.
    Zaldonts, D. B.
    Johnson, B. A.
    Studer, S. M.
    Toyoda, Y.
    Bermudez, C. A.
    Hattler, B. G.
    Pilewski, J. M.
    McCurry, K. R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2009, 28 (02): : S68 - S68
  • [34] Does lymphocyte count after rabbit antithymocyte globulin induction therapy matter in pancreas transplantation?
    Perosa, Marcelo
    Danziere, Fernanda
    Vidigal, Ana Claudia
    Souza, Luiza R.
    Andalaft, Julia
    TRANSPLANTATION, 2023, 107 (10) : 73 - 73
  • [35] Rabbit antithymocyte globulin versus OKT3 induction therapy after heart-lung and lung transplantation: effect on survival, rejection, infection, and obliterative bronchiolitis
    Barlow, CN
    Moon, MR
    Green, GR
    Gamberg, P
    Theodore, J
    Reitz, BA
    Robbins, RC
    TRANSPLANT INTERNATIONAL, 2001, 14 (04) : 234 - 239
  • [36] Long-Term Outcomes following Alemtuzumab Induction in Lung Transplantation
    Wehman, Brody
    Griffith, Bartley P.
    Balwan, Akshu
    Kon, Zachary N.
    Suffredini, Dante A.
    Evans, Charles
    Garcia, Jose P.
    Iacono, Aldo
    HEART SURGERY FORUM, 2013, 16 (05): : E252 - E256
  • [37] Basiliximab versus rabbit antithymocyte globulin as induction therapy for living-related renal transplantation: a single-center experience
    Hong-Feng Huang
    Jing-Yi Zhou
    Wen-Qing Xie
    Jian-Yong Wu
    Hao Deng
    Jiang-Hua Chen
    International Urology and Nephrology, 2016, 48 : 1363 - 1370
  • [38] Induction therapy with rabbit antithymocyte globulin versus basiliximab after kidney transplantation: a health economic analysis from a German perspective
    Cremaschi, Liana
    von Versen, Regina
    Benzing, Thomas
    Wiesener, Michael
    Zink, Nikolai
    Milkovich, Gary
    Paivanas, Thomas
    Gallagher, Meghan
    Thaiss, Friedrich
    TRANSPLANT INTERNATIONAL, 2017, 30 (10) : 1011 - 1019
  • [39] Basiliximab versus rabbit antithymocyte globulin as induction therapy for living-related renal transplantation: a single-center experience
    Huang, Hong-Feng
    Zhou, Jing-Yi
    Xie, Wen-Qing
    Wu, Jian-Yong
    Deng, Hao
    Chen, Jiang-Hua
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2016, 48 (08) : 1363 - 1370
  • [40] Comparison of outcomes of immunosuppressive therapy with rabbit versus horse antithymocyte globulin and cyclosporine a in children with acquired severe aplastic anemia
    Yoshimi, Ayami
    Noellke, Peter
    Stary, Jan
    Kallay, Krisztian
    Smith, Owen
    Locatelli, Franco
    Buechner, Jochen
    Bodova, Ivana
    Sevilla, Julian
    Schmugge, Markus
    Bierings, Marc
    Masmas, Tania
    Dworzak, Michael
    Labarque, Veerle
    Pawelec, Katarzyna
    Jahnukainen, Kirsi
    Polychronopoulou, Sophia
    Kjollerstrom, Paula
    Kavcic, Marko
    Erlacher, Miriam
    Niemeyer, Charlotte M.
    Strahm, Brigitte
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (07) : 1403 - 1406
12345